|
|
|||
| |||||||||||||||||||||||||||||||
The treatment of cancer in older people is an increasingly common problem that is widely acknowledged but poorly understood. The benefits of treatment are smaller for older patients than for younger ones because of the shorter life expectancy of the former. Moreover, the therapeutic risks are increased in elderly patients because of a reduction in the functional reserve of multiple organ systems and the high prevalence of coexisting conditions. Since aging is highly individualized and the older population is diverse, perhaps the main challenge in managing cancer in older patients is to identify those who may benefit and those who
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |